DUBLIN--(BUSINESS WIRE)--The "Cardiac Electrophysiology Mapping, Navigation and Recording Devices Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. The ...

CARLSBAD, Calif. and BERLIN, May 20, 2020 /PRNewswire/ -- Acutus Medical and BIOTRONIK today announced a new alliance to provide a comprehensive portfolio of electrophysiology, mapping, ablation and ...

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the market for electrophysiology (EP) mapping and ablation ...

MedTech Insights report series analyzes the impact of recent breakthroughs in pulsed-field ablation, signaling its promising future in the electrophysiology mapping and ablation device market Andrew ...

(MENAFN- PR Newswire) HERDECKE, Germany, Oct. 7, 2019 /PRNewswire/ -- EP Map System, GmbH, a Herdecke, Germany-based company that has developed a suite of technologies focused on electrophysiology (EP ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Stereotaxis has announced the submission of the MAGiC Sweep™ catheter for FDA approval, marking the first high-density electrophysiological (EP) mapping catheter designed for robotic navigation using ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

- EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise ABBOTT PARK, Ill., Jan.

Acutus Medical Inc AFIB announced a realignment of resources and corporate restructuring to become a contract manufacturing business that could generate positive cash flow over the next several years.

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory submission for the MAGiC Sweep™ catheter.